CIK 0001108205
- Non-accelerated filer
- Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043505116
- Phone
- +1 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- 4 Open-market sale President and CEO sold 12,500 shares at an average $4.63 ($57,832)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at $4.62 ($46,242)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $4.97 ($49,741)
- 4 Open-market sale President and CEO sold 120,000 shares at an average $5.01 ($600,984)
- 4 Open-market sale Vice President,General Counsel sold 21,875 shares at an average $4.83 ($105,616)
- 4 Open-market sale Chief Financial Officer sold 18,107 shares at an average $4.51 ($81,682)
- 4 Open-market buy Director bought 60,975 shares at an average $4.07 ($248,140)
- 4 Open-market sale Chief Financial Officer sold 11,250 shares at $4.55 ($51,188)
- 4 Open-market sale Vice President,General Counsel sold 6,250 shares at $4.25 ($26,563)
- 4 Exercise or conversion Director acquired 65,625 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 20 of 24 · 475 filings